Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Autoimmunity in Primary T-Cell Immunodeficiencies Publisher Pubmed



Azizi G1, 2 ; Ghanavatinejad A3 ; Abolhassani H2, 4 ; Yazdani R5 ; Rezaei N2 ; Mirshafiey A3 ; Aghamohammadi A2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Laboratory Medicine, Imam Hassan Mojtaba Hospital, Alborz University of Medical Sciences, Karaj, Iran
  2. 2. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden
  5. 5. Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Expert Review of Clinical Immunology Published:2016


Abstract

Primary immunodeficiency diseases (PID) are a genetically heterogeneous group of more than 270 disorders that affect distinct components of both humoral and cellular arms of the immune system. Primary T cell immunodeficiencies affect subjects at the early age of life. In most cases, T-cell PIDs become apparent as combined T- and B-cell deficiencies. Patients with T-cell PID are prone to life-threatening infections. On the other hand, non-infectious complications such as lymphoproliferative diseases, cancers and autoimmunity seem to be associated with the primary T-cell immunodeficiencies. Autoimmune disorders of all kinds (organ specific or systemic ones) could be subjected to this class of PIDs; however, the most frequent autoimmune disorders are immune thrombocytopenic purpura (ITP) and autoimmune hemolytic anemia (AIHA). In this review, we discuss the proposed mechanisms of autoimmunity and review the literature reported on autoimmune disorder in each type of primary T-cell immunodeficiencies. © 2016 Informa UK Limited, trading as Taylor & Francis Group.
Other Related Docs
9. Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort, Journal of Allergy and Clinical Immunology: In Practice (2019)
13. A Review on Defects of Dendritic Cells in Common Variable Immunodeficiency, Endocrine, Metabolic and Immune Disorders - Drug Targets (2017)
14. Infectious and Noninfectious Pulmonary Complications in Patients With Primary Immunodeficiency Disorders, Journal of Investigational Allergology and Clinical Immunology (2017)
16. Role of Rare Immune Cells in Common Variable Immunodeficiency, Pediatric Allergy and Immunology (2022)
23. Role of Apoptosis in the Pathogenesis of Common Variable Immunodeficiency (Cvid), Endocrine, Metabolic and Immune Disorders - Drug Targets (2017)
36. Primary Antibody Deficiency in a Tertiary Referral Hospital: A 30-Year Experiment, Journal of Investigational Allergology and Clinical Immunology (2015)
39. Immunodeficiencies Affecting Cellular and Humoral Immunity, Inborn Errors of Immunity: A Practical Guide (2021)
43. Noninfectious Complications in B-Lymphopenic Common Variable Immunodeficiency, Journal of Investigational Allergology and Clinical Immunology (2024)
44. Il-22 Produced by T Helper Cell 22 As a New Player in the Pathogenesis of Immune Thrombocytopenia, Endocrine, Metabolic and Immune Disorders - Drug Targets (2015)
46. The Use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases, Endocrine, Metabolic and Immune Disorders - Drug Targets (2016)